Anzeige
Mehr »
Login
Donnerstag, 13.05.2021 Börsentäglich über 12.000 News von 658 internationalen Medien
Das Vatertagsgeschenk für jeden Spekulanten?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A110V2 ISIN: US03820J1007 Ticker-Symbol: 2GT 
Tradegate
12.05.21
17:10 Uhr
3,180 Euro
+0,140
+4,61 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
APPLIED GENETIC TECHNOLOGIES CORPORATION Chart 1 Jahr
5-Tage-Chart
APPLIED GENETIC TECHNOLOGIES CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
3,0803,24012:27
3,1603,26012:32

Aktuelle News zur APPLIED GENETIC TECHNOLOGIES Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiAGTC reports process development advances of XLRP gene therapy candidate at ASGCT2
06.05.APPLIED GENETIC TECHNOLOGIES CORP - 8-K, Current Report3
APPLIED GENETIC TECHNOLOGIES Aktie jetzt für 0€ handeln
06.05.Applied Genetic's XLRP Gene Therapy Shows Improved, Durable Response In Retinal Sensitivity4
05.05.Applied Genetic Technologies Corporation: AGTC to Host Conference Call on May 6 at 8:00 AM ET to Discuss XLRP Full 12-Month Data from Highest Dose Groups ...6
04.05.Applied Genetic Technologies Corporation: AGTC Advances in AAV Gene Therapy Manufacturing to be Presented at the American Society of Gene & Cell Therapy ...1
03.05.Applied Genetic Technologies Corporation: AGTC Clinical Investigators Provide Encore Presentation of Data from the Company's Ongoing XLRP and Achromatopsia ...6
29.04.Applied Genetic Technologies Corporation: AGTC Announces Data to be Presented from the Ongoing XLRP and Achromatopsia Clinical Trials at the ARVO 2021 ...2
28.04.Otonomy, Inc.: Otonomy and AGTC to Present Preclinical Proof-of-Concept Results for OTO-825 Gene Therapy at ASGCT Annual Meeting12
26.04.HSII, RRR, VNET and AGTC among after-hours movers6
26.04.APPLIED GENETIC TECHNOLOGIES CORP - 8-K, Current Report7
19.04.Applied Genetic licenses promoter technology to SparingVision SAS10
13.04.Applied Genetic and TeamedOn ink licensing deal for gene therapy development18
13.04.Applied Genetic Technologies Corporation: TeamedOn and AGTC Announce a Licensing Agreement Advancing X-Linked Retinoschisis Gene Therapy Program7
02.04.APPLIED GENETIC TECHNOLOGIES CORP - 8-K, Current Report24
31.03.Applied Genetic Technologies Corporation: AGTC to Participate in Upcoming Virtual Biotech Corporate Access Day and Cell and Gene Conference14
18.03.Applied Genetic Technologies Corporation: AGTC to Present at the Gene Therapy Patient Engagement Summit, Held Virtually, March 24, 202118
02.03.Applied Genetic Technologies Corporation: AGTC to Present at Upcoming Investor Conferences29
16.02.Applied Genetic Technologies Corporation: AGTC to Present at the OIS Gene Therapy Innovation Showcase on February 18, 202161
16.02.Applied Genetic Technologies: Leader Among Larger Peers In Gene Therapies For Certain Eye Diseases32
16.02.Applied Genetic Technologies Corporation: AGTC to Present at the 4th Annual Gene Therapy for Rare Disorders Digital Event, February 22-25, 20217
Seite:  Weiter >>
38 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,10